- Home
- MGPI vs ATYR Comparison
MGPI vs ATYR Comparison
Compare MGPI & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGPI
- ATYR
- Stock Information
- Founded
- MGPI 1941
- ATYR 2005
- Country
- MGPI United States
- ATYR United States
- Employees
- MGPI N/A
- ATYR N/A
- Industry
- MGPI Beverages (Production/Distribution)
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MGPI Consumer Staples
- ATYR Health Care
- Exchange
- MGPI Nasdaq
- ATYR Nasdaq
- Market Cap
- MGPI 610.9M
- ATYR 535.0M
- IPO Year
- MGPI 1988
- ATYR 2015
- Fundamental
- Price
- MGPI $27.57
- ATYR $1.03
- Analyst Decision
- MGPI Strong Buy
- ATYR Buy
- Analyst Count
- MGPI 5
- ATYR 6
- Target Price
- MGPI $45.40
- ATYR $8.88
- AVG Volume (30 Days)
- MGPI 186.0K
- ATYR 15.6M
- Earning Date
- MGPI 10-30-2025
- ATYR 11-06-2025
- Dividend Yield
- MGPI 1.75%
- ATYR N/A
- EPS Growth
- MGPI N/A
- ATYR N/A
- EPS
- MGPI N/A
- ATYR N/A
- Revenue
- MGPI $609,404,000.00
- ATYR N/A
- Revenue This Year
- MGPI N/A
- ATYR $420.85
- Revenue Next Year
- MGPI N/A
- ATYR $1,919.44
- P/E Ratio
- MGPI N/A
- ATYR N/A
- Revenue Growth
- MGPI N/A
- ATYR N/A
- 52 Week Low
- MGPI $25.12
- ATYR $0.97
- 52 Week High
- MGPI $86.35
- ATYR $7.29
- Technical
- Relative Strength Index (RSI)
- MGPI 40.60
- ATYR 22.25
- Support Level
- MGPI $27.50
- ATYR $1.00
- Resistance Level
- MGPI $28.45
- ATYR $6.50
- Average True Range (ATR)
- MGPI 0.81
- ATYR 0.46
- MACD
- MGPI -0.12
- ATYR -0.51
- Stochastic Oscillator
- MGPI 7.84
- ATYR 1.01
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.